loadpatents
name:-0.0066289901733398
name:-0.0048201084136963
name:-0.003364086151123
GEORGANTAS, III; Robert W. Patent Filings

GEORGANTAS, III; Robert W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for GEORGANTAS, III; Robert W..The latest application filed is for "method for predicting risk of unfavorable outcomes, e.g., in covid-19 hospitalization, from clinical characteristics and basic laboratory findings".

Company Profile
2.4.6
  • GEORGANTAS, III; Robert W. - Broomfield CO
  • Georgantas, III; Robert W. - Gaithersburg MD
  • Georgantas, III; Robert W. - Towson MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings
App 20220189638 - CAMPBELL; Thomas ;   et al.
2022-06-16
Interpretation Of Machine Learning Classifications In Clinical Diagnostics Using Shapely Values And Uses Thereof
App 20220188701 - RODER; Heinrich ;   et al.
2022-06-16
Ccl20 As A Predictor Of Clinical Response To Il23-antagonists
App 20220144935 - Georgantas, III; Robert W. ;   et al.
2022-05-12
CCL20 as a predictor of clinical response to IL23-antagonists
Grant 11,220,541 - Georgantas, III , et al. January 11, 2
2022-01-11
Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers
Grant 11,016,099 - Georgantas, III , et al. May 25, 2
2021-05-25
Ccl20 As A Predictor Of Clinical Response To Il23-antagonists
App 20200262907 - Georgantas, III; Robert W. ;   et al.
2020-08-20
Prediction Of Clinical Response To Il23-antagonists Using Il23 Pathway Biomarkers
App 20180252728 - Georgantas, III; Robert W. ;   et al.
2018-09-06
Recombinant polypeptide production
Grant 10,006,026 - Streicher , et al. June 26, 2
2018-06-26
Recombinant Polypeptide Production
App 20160024502 - STREICHER; Katie ;   et al.
2016-01-28
Therapeutic and diagnostic applications of genes differentially expressed in lympho-hematopoietic stem cells
Grant 7,799,528 - Civin , et al. September 21, 2
2010-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed